(AP) — Drug developer Abbott Laboratories Inc. said Wednesday its third-quarter profit jumped 51 percent, led by sales of the arthritis medication Humira and a steep increase in sales of stents and other heart-related devices. The company also raised its full-year outlook based on higher ...
Copyright CRAIN - Crain's
